We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vasoactive Hormones During the Night in Patients With Obstructive Sleep Apnea and Healthy Controls.

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00291993
First Posted: February 15, 2006
Last Update Posted: April 21, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Regional Hospital Holstebro
February 13, 2006
February 15, 2006
April 21, 2008
January 2004
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00291993 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Vasoactive Hormones During the Night in Patients With Obstructive Sleep Apnea and Healthy Controls.
Not Provided

Obstructive sleep apnea syndrome is complicated by considerable cardiovascular morbidity and mortality, at least partly due to hypertension. Nocturnal hypoxia, hypercapnia and acidosis stimulate chemoreceptors and presumably increased secretion of vasoactive hormones which might be responsible for hypertension in these patients.

The aim of this study is to measure the secretion of vasoactive hormones at night and to analyse the relationship between vasoactive hormones, oxygen saturation and the blood pressure at night.

Not Provided
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
  • Healthy
  • Obstructive Sleep Apnea
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

Male and female Age 20-65 Obstructive sleep apnea

Exclusion Criteria:

Drug or alcohol abuse Pregnancy or breast feeding Cancer Clinical signs or history of disease in the heart, lungs, kidney or endocrine organs Abnormal laboratory tests Albuminuria or glucosuria Aterial hypertension for healthy subjects

Sexes Eligible for Study: All
20 Years to 65 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Denmark
 
 
NCT00291993
MED.RES.HOS.2004.01.PHH
Not Provided
Not Provided
Not Provided
Not Provided
Regional Hospital Holstebro
Not Provided
Study Chair: Erling B Pedersen, Professor Holstebro Hospital, Department of Medical Research
Principal Investigator: Pia H Hansen, MD Holstebro Hospital, Department of Medical Research
Regional Hospital Holstebro
April 2008